financetom
Business
financetom
/
Business
/
BRIEF-Tradeweb To Acquire Independent, Multi-Fund Investment Platform ICD
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Tradeweb To Acquire Independent, Multi-Fund Investment Platform ICD
Apr 8, 2024 3:56 AM

April 8 (Reuters) - Tradeweb Markets Inc ( TW ):

* TRADEWEB TO ACQUIRE ICD, A LEADING INDEPENDENT, MULTI-FUND

INVESTMENT PLATFORM FOR CORPORATE TREASURY PROFESSIONALS

* TRADEWEB MARKETS INC ( TW ): PROPOSED DEAL FOR $785 MILLION

* TRADEWEB MARKETS INC ( TW ) - ACQUISITION IS EXPECTED TO BE

ACCRETIVE

TO TRADEWEB'S ADJUSTED EARNINGS PER SHARE IN FIRST 12 MONTHS

FOLLOWING CLOSING

* TRADEWEB MARKETS INC ( TW ) - PURCHASE PRICE IS EXPECTED TO BE

FUNDED

WITH CASH ON HAND.

* TRADEWEB MARKETS INC ( TW ): UPON DEAL CLOSING, ICD'S CEO TORY

HAZARD

TO REPORT TO TRADEWEB PRESIDENT THOMAS PLUTA, WILL JOIN

TRADEWEB'S OPERATING COMMITTEE

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novavax Secures EU Marketing Authorization for Updated Nuvaxovid COVID-19 Vaccine
Novavax Secures EU Marketing Authorization for Updated Nuvaxovid COVID-19 Vaccine
Oct 9, 2024
07:33 AM EDT, 10/09/2024 (MT Newswires) -- Novavax ( NVAX ) said Wednesday that the European Commission granted the marketing authorization for its updated Nuvaxovid COVID-19 vaccine for use in individuals of at least 12 years old. The company said the approval was based on non-clinical data that showed Nuvaxovid's cross-reactivity across several JN.1 lineage viruses. Novavax ( NVAX )...
Can-Fite BioPharma Says Its Pancreatic Cancer Drug Candidate Receives US FDA Orphan Drug Designation
Can-Fite BioPharma Says Its Pancreatic Cancer Drug Candidate Receives US FDA Orphan Drug Designation
Oct 9, 2024
07:51 AM EDT, 10/09/2024 (MT Newswires) -- Can-Fite BioPharma ( CANF ) said Wednesday that its oncology drug candidate Namodenoson, whihc treats pancreatic cancer, has received Orphan Drug Designation from the US Food and Drug Administration. The company said it is now finalizing all preparatory requirements for a mid-stage trial in participants suffering from pancreatic cancer to evaluate the safety,...
More airlines fly over Afghanistan in last week as Middle East tensions rise
More airlines fly over Afghanistan in last week as Middle East tensions rise
Oct 9, 2024
LONDON/KABUL (Reuters) - Airlines have diverted more flights over Afghanistan over the past week to avoid Iranian airspace, data shows, adding to journey times and fuel costs in the latest disruption for routes between Asia and Europe as tensions in the Middle East escalate. Flights over Afghanistan were already growing in recent months, but expectations of an Israeli response to...
Column-Jamie Dimon questions public funds' private investments: Ross Kerber
Column-Jamie Dimon questions public funds' private investments: Ross Kerber
Oct 9, 2024
(Reuters) - JPMorgan Chase & Co ( JPM ) CEO Jamie Dimon recently confronted public pension fund managers about channeling more of their investments into private assets, a trend he said could be at odds with their stated policy concerns. You call me up and talk to us about all the issues you're interested in. But when you make huge...
Copyright 2023-2026 - www.financetom.com All Rights Reserved